Yulan Li

Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III Study

Marc I. Lorber, Shamkant Mulgaonkar, Khalid M.H. Butt et al. · Transplantation · 2005 · 232 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

Raimund Margreiter, Willem Weimar, Jacques Dantal et al. · American Journal of Transplantation · 2005 · 218 citations

Medicine, Nephrology, Pharmacology +17

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Ayman Al‐Hendy, Andrea S. Lukes, Alfred N. Poindexter et al. · New England Journal of Medicine · 2021 · 201 citations · Full text

Medicine, Gynecology, Pharmacotherapy +17

Everolimus (Certican) 12-Month Safety and Efficacy Versus Mycophenolate Mofetil in de Novo Renal Transplant Recipients

Raimund Margreiter, Willem Weimar, Jacques Dantal et al. · Transplantation · 2004 · 160 citations

Medicine, Nephrology, Pharmacotherapy +17

Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)

Linda C. Giudice, Sawsan As‐Sanie, Juan Camilo Arjona Ferreira et al. · The Lancet · 2022 · 152 citations · Full text

Medicine, Endocrinology, Gynecology +15